Ascend Pain & Wellness, a leading provider of advanced pain management and vascular treatments, announces the launch of its new minimally invasive hysterectomy alternative: uterine fibroid embolization (UFE). This groundbreaking procedure offers women suffering from uterine fibroids a non-surgical option that preserves the uterus and reduces recovery time.
Uterine fibroids affect a significant number of women, often leading to symptoms such as heavy menstrual bleeding, pelvic pain, and reproductive issues. While hysterectomy has been a common solution, many women seek uterine fibroid treatment without surgery to avoid the health risks and downtime associated with invasive procedures.
Ascend Pain & Wellness provides an effective alternative through its uterine fibroid embolization treatment. It is a minimally invasive procedure performed by interventional radiologists. It involves blocking the blood flow to the fibroids, causing them to shrink. In this way, a patient's symptoms will improve. This uterine artery embolization treatment, therefore, allows patients to return to their normal activities much sooner than traditional surgery.
Ascend Pain & Wellness focuses on providing cutting-edge treatments that improve patient outcomes. The introduction of uterine fibroid embolization reflects its emphasis on minimally invasive techniques that reduce patient discomfort and recovery time.
With locations serving Westchester, IL, and the surrounding areas, Ascend Pain & Wellness offers a comprehensive range of pain management and vascular services. Its team of experienced physicians specializes in procedures such as nerve blocks, spinal injections, vertebral augmentation, and treatments for conditions like peripheral arterial disease (PAD), deep vein thrombosis (DVT), prostate enlargement, and varicose veins.
In the vascular domain, Ascend Pain & Wellness offers treatments for peripheral arterial disease (PAD), providing patients with options to improve circulation and reduce symptoms such as leg pain and cramping. For those suffering from deep vein thrombosis (DVT), the clinic provides interventions aimed at dissolving clots and preventing complications.
Men experiencing symptoms of prostate enlargement can benefit from the clinic's minimally invasive prostate artery embolization procedure. It reduces prostate size and alleviates urinary symptoms without the need for surgery.
Varicose veins, a common condition affecting many individuals, are also treated at Ascend Pain & Wellness. The clinic offers endovenous laser treatment and other minimally invasive options to relieve discomfort and improve the appearance of affected veins.
Patients seeking uterine fibroid treatment can benefit from the expertise of Ascend Pain & Wellness medical team. The uterine fibroid embolization treatment not only addresses the symptoms but also offers a fertility-preserving option for women who wish to have children in the future. Women experiencing symptoms of uterine fibroids are encouraged to consult with the specialists at Ascend Pain & Wellness to determine if uterine fibroid embolization is an appropriate treatment option for them.
The clinic's pain management services encompass a variety of procedures designed to alleviate chronic pain conditions. Treatments such as nerve blocks and spinal injections are performed using the latest techniques to maximize effectiveness and minimize discomfort.
Learn more about the new minimally invasive hysterectomy alternative by visiting Ascend Pain & Wellness’ website at https://www.ascendpainandwellness.com/vascular/fibroid.
About Ascend Pain & Wellness
Ascend Pain & Wellness is a premier medical clinic located in Westchester, Illinois, specializing in advanced pain management and vascular treatments. Utilizing minimally invasive techniques, it offers personalized care to improve patient outcomes and enhance quality of life.
###
Media Contact
Ascend Pain & Wellness
Address: 947 S. Mannheim Road, Westchester, IL 60154
Phone: (708) 550-7005
Website: https://www.ascendpainandwellness.com/
Source: 38 Digital Market News
Release ID: 1231812